In the Boardroom
Refine Search
Pharmaceutical
Global specialty pharma company Reckitt Benckiser has appointed Cary Claiborne as chief financial officer. 4 November 2014
Pharmaceutical
Rare disease specialist aTyr Pharma has appointed Fred Ramsdell as vice president of immunology. 3 November 2014
Biotechnology
Synthetic biology company Synthetic Genomics has appointed Oliver Fetzer as the company’s new chief executive. 29 October 2014
Pharmaceutical
Just a day after French pharma major Sanofi denied that the future of its chief executive was under discussion, at a board meeting convened at 8am this morning it decided unanimously to remove Christopher Viehbacher as chief executive of the company. 29 October 2014
Pharmaceutical
Chris Viehbacher, chief executive of French drug major Sanofi, has urged the company’s board to clarify rumors that he is to be dismissed, according to a letter published in French business newspaper Les Echos. 28 October 2014
Biotechnology
Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed Warren Sherman as chief medical officer. 23 October 2014
Biotechnology
US rare disease company aTyr Pharma has named John McKew as vice president of research. 22 October 2014
article
UK-based inflammatory disease and cancer specialist Karus Therapeutics has appointed Simon Roitt as head of clinical development and Peter Finan as head of biology. 21 October 2014
article
Therapeutic antibody specialist AnaptysBio has appointed Marco Londei as chief development officer, leading the preclinical and clinical development of AnaptysBio’s proprietary antibody pipeline. 20 October 2014
Pharmaceutical
German pharma company Grünenthal Group has appointed Sascha Becker as group chief financial officer, commencing in the first quarter of 2015. 20 October 2014
Pharmaceutical
James Bowling, interim chief financial officer of Ireland-headquartered drugmaker Shire, has stepped down from the position. 20 October 2014
Pharmaceutical
Swedish drug developer Karolinska Development has named Bruno Lucidi as permanent chief executive. 15 October 2014
Pharmaceutical
Although life science company boards are recruiting more women, a lack of managing their talent during their career is slowing the progress towards greater diversity, according to life sciences human resources specialist RSA’s biannual survey of non-executive directors. 14 October 2014
Pharmaceutical
Swedish orphan and niche product specialist Pharmalink has appointed Bengt Julander as chairman of the board of directors, replacing Anders Wiklund. 14 October 2014
Pharmaceutical
Swiss drug major Novartis has announced that three members of its executive committee will leave the company. 9 October 2014
Pharmaceutical
European specialty pharmaceutical company Norgine has appointed Christopher Bath as vice president of global finance. 8 October 2014
Pharmaceutical
Japan’s largest drugmaker Takeda Pharmaceutical has appointed John Boslego as senior vice president and head of development for the company’s global vaccine business unit. 8 October 2014
Pharmaceutical
Canadian biopharmaceutical company Aeterna Zentaris has named Philip Theodore as senior vice president, chief administrative officer, general counsel and corporate secretary. 7 October 2014
Biotechnology
PDL BioPharma has appointed Danny Hart as vice president of business development. 6 October 2014
Pharmaceutical
Satish Jindal has been appointed to lead the discovery of drug candidates from leading academic institutions at Allied-Bristol Life Sciences, a jointly-owned enterprise between Allied Minds and US drug major Bristol-Myers Squibb. 6 October 2014
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
French cancer vaccine focused biotech Oncovita has appointed Dr Stéphane Altaba as its new chief executive (CEO). 9 October 2024
Biotechnology
Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including seed financing and Series A. 7 October 2024
Biotechnology
Mosaic Therapeutics, a UK-based oncology therapeutics company dedicated to resolving cancer’s complexity to power new combination therapies for patients, has announced the appointment of Barry Davies as chief scientific officer. 7 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze